HomeHIK • LON
Follow
Hikma Pharmaceuticals Plc
Previous close
GBX 1,880.50
Day range
GBX 1,887.50 - GBX 1,938.00
Year range
GBX 1,614.50 - GBX 2,222.00
Market cap
4.26B GBP
Avg Volume
534.62K
P/E ratio
28.41
Dividend yield
2.97%
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 724.00M | 11.04% |
Operating expense | 180.00M | 3.15% |
Net income | 29.50M | 293.33% |
Net profit margin | 4.07 | 253.91% |
Earnings per share | — | — |
EBITDA | 175.00M | -8.62% |
Effective tax rate | 22.78% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 205.00M | -29.79% |
Total assets | 4.68B | 4.67% |
Total liabilities | 2.47B | 6.37% |
Total equity | 2.21B | — |
Shares outstanding | 220.72M | — |
Price to book | 1.89 | — |
Return on assets | 8.41% | — |
Return on capital | 11.58% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 29.50M | 293.33% |
Cash from operations | 193.00M | 6.93% |
Cash from investing | -107.00M | -111.88% |
Cash from financing | -119.50M | 31.52% |
Net change in cash | -33.50M | 33.66% |
Free cash flow | 71.06M | -17.79% |
About
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. Wikipedia
Founded
1978
Website
Employees
9,100